Question special
Lead Moderator

Great comments everyone. A common theme seems to be regarding the flow of information. Patients hear about amazing new therapies online, in the media, from word of mouth etc. Additionally, with the prospects of next generation genome editing tools, there is even more promise for better stem cell therapies and thus more hype.

In the NEJM perspective piece, Charo discusses how media attention from clinical trial results and exciting new gene editing results may misinform patients. What can be done to properly inform these patients? And, what about clinicians? Do they need to be better educated to deal with the issues of stem cell tourism?